Free Trial

Vanda Pharmaceuticals (VNDA) Competitors

Vanda Pharmaceuticals logo
$4.74 -0.05 (-1.04%)
Closing price 04:00 PM Eastern
Extended Trading
$4.74 0.00 (0.00%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VNDA vs. OPK, GERN, ZBIO, RGLS, LXRX, MYGN, EBS, RIGL, XOMA, and VSTM

Should you be buying Vanda Pharmaceuticals stock or one of its competitors? The main competitors of Vanda Pharmaceuticals include OPKO Health (OPK), Geron (GERN), Zenas BioPharma (ZBIO), Regulus Therapeutics (RGLS), Lexicon Pharmaceuticals (LXRX), Myriad Genetics (MYGN), Emergent Biosolutions (EBS), Rigel Pharmaceuticals (RIGL), XOMA Royalty (XOMA), and Verastem (VSTM). These companies are all part of the "biotechnology" industry.

Vanda Pharmaceuticals vs. Its Competitors

OPKO Health (NASDAQ:OPK) and Vanda Pharmaceuticals (NASDAQ:VNDA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

Vanda Pharmaceuticals has lower revenue, but higher earnings than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than Vanda Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OPKO Health$713.10M1.52-$53.22M-$0.07-19.57
Vanda Pharmaceuticals$198.77M1.41-$18.90M-$0.75-6.32

In the previous week, Vanda Pharmaceuticals had 2 more articles in the media than OPKO Health. MarketBeat recorded 4 mentions for Vanda Pharmaceuticals and 2 mentions for OPKO Health. OPKO Health's average media sentiment score of 0.93 beat Vanda Pharmaceuticals' score of 0.47 indicating that OPKO Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OPKO Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Vanda Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

OPKO Health has a net margin of -5.66% compared to Vanda Pharmaceuticals' net margin of -21.98%. OPKO Health's return on equity of -2.85% beat Vanda Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
OPKO Health-5.66% -2.85% -1.82%
Vanda Pharmaceuticals -21.98%-8.30%-6.85%

64.6% of OPKO Health shares are held by institutional investors. Comparatively, 88.1% of Vanda Pharmaceuticals shares are held by institutional investors. 49.7% of OPKO Health shares are held by insiders. Comparatively, 10.0% of Vanda Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

OPKO Health has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500. Comparatively, Vanda Pharmaceuticals has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500.

OPKO Health currently has a consensus target price of $2.75, suggesting a potential upside of 100.73%. Vanda Pharmaceuticals has a consensus target price of $16.50, suggesting a potential upside of 248.10%. Given Vanda Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Vanda Pharmaceuticals is more favorable than OPKO Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OPKO Health
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00
Vanda Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50

Summary

OPKO Health beats Vanda Pharmaceuticals on 10 of the 16 factors compared between the two stocks.

Get Vanda Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for VNDA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VNDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VNDA vs. The Competition

MetricVanda PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$282.30M$3.07B$5.70B$9.51B
Dividend YieldN/A2.36%4.69%4.01%
P/E Ratio-6.3221.0428.0720.05
Price / Sales1.41284.46448.5799.42
Price / CashN/A42.7636.2258.56
Price / Book0.518.378.665.87
Net Income-$18.90M-$55.19M$3.25B$258.55M
7 Day Performance-0.84%5.89%4.20%2.23%
1 Month Performance2.82%17.63%10.82%12.76%
1 Year Performance-22.93%5.09%34.70%19.36%

Vanda Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VNDA
Vanda Pharmaceuticals
4.7395 of 5 stars
$4.74
-1.0%
$16.50
+248.1%
-22.4%$282.30M$198.77M-6.32290Upcoming Earnings
OPK
OPKO Health
3.8825 of 5 stars
$1.40
+3.7%
$2.75
+96.4%
-1.4%$1.07B$713.10M-20.002,997Positive News
GERN
Geron
3.3916 of 5 stars
$1.23
-0.8%
$4.61
+274.9%
-70.2%$789.78M$76.99M-5.8670Analyst Revision
ZBIO
Zenas BioPharma
1.7332 of 5 stars
$14.29
+4.1%
$36.67
+156.6%
N/A$574.38M$5M0.00N/ANews Coverage
RGLS
Regulus Therapeutics
1.6496 of 5 stars
$8.16
flat
$8.50
+4.2%
N/A$564.92MN/A-11.1830
LXRX
Lexicon Pharmaceuticals
2.4823 of 5 stars
$1.23
flat
$3.67
+198.1%
-47.9%$444.64M$31.08M0.00140
MYGN
Myriad Genetics
4.5597 of 5 stars
$4.45
-0.4%
$14.38
+223.2%
-83.4%$412.03M$837.60M0.002,700News Coverage
EBS
Emergent Biosolutions
4.3363 of 5 stars
$6.93
+0.0%
$14.33
+106.8%
-45.8%$376.14M$1.04B-2.562,420News Coverage
Positive News
RIGL
Rigel Pharmaceuticals
3.202 of 5 stars
$19.59
+4.2%
$36.40
+85.8%
+94.0%$336M$179.28M9.08160Positive News
XOMA
XOMA Royalty
4.0741 of 5 stars
$25.48
-0.7%
$69.50
+172.8%
-8.6%$307.19M$28.49M0.0010
VSTM
Verastem
3.4967 of 5 stars
$5.10
-1.2%
$13.38
+162.3%
+78.7%$283.54M$10K0.0050

Related Companies and Tools


This page (NASDAQ:VNDA) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners